Table 1 Baseline participant’s characteristics
Placebo (n = 75) | Vitamin D (n = 57) | P-value between groups | |
|---|---|---|---|
Age (years), mean ± SD | 44.89 ± 8.88 | 45.51 ± 8.96 | 0.69 |
Gender (male), n (%) | 63 (84.0) | 47 (82.5) | 0.81 |
Ethnicity (Arab), n (%) | 48 (64.0) | 23 (40.4) | 0.007 |
25(OH) D (< 20 ng/ml), n (%) | 55 (73.3) | 45 (83.3) | 0.18 |
Family history of diabetes (yes), n (%) | 52 (69.3) | 44 (77.2) | 0.31 |
Family history of IHD (yes), n (%) | 15 (20.3) | 13 (23.2) | 0.68 |
Family history of HTN (yes), n (%) | 43 (58.1) | 31 (55.4) | 0.75 |
Physically active for at least 30 min per day (yes), n (%) | 29 (38.7) | 21 (37.5) | 0.89 |
High blood glucose history (yes), n (%) | 9 (12.0) | 6 (10.5) | 0.79 |
FINDRISC score, mean ± SD | 12.01 ± 4.00 | 11.96 ± 4.05 | 0.94 |